- Home
- RGNX vs PACB Comparison
RGNX vs PACB Comparison
Compare RGNX & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGNX | PACB |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 528.6M | 462.8M |
| IPO Year | 2015 | 2010 |
Fundamental Metrics
Financial Performance| Metric | RGNX | PACB |
|---|---|---|
| Price | $11.90 | $1.73 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | ★ $28.75 | $1.67 |
| AVG Volume (30 Days) | 2.1M | ★ 6.4M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $10,393,000.00 | ★ $93,468,000.00 |
| Revenue This Year | $51.21 | $11.32 |
| Revenue Next Year | $19.08 | $12.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 126.48 | 3.04 |
| 52 Week Low | $5.46 | $1.09 |
| 52 Week High | $16.19 | $2.73 |
Technical Indicators
Market Signals| Indicator | RGNX | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 79.66 | 68.43 |
| Support Level | $10.75 | $1.68 |
| Resistance Level | $12.05 | $1.78 |
| Average True Range (ATR) | 0.87 | 0.11 |
| MACD | 0.57 | 0.04 |
| Stochastic Oscillator | 96.16 | 89.69 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.